Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Instil Bio, Inc.TIL · Entity 7177 | Director | June 11, 2026 | June 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Instil Bio, Inc.
Report date June 11, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.93 · Expires 2036-06-10 | Direct | 6,500 |
Reported balance
After 2026-06-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-11 · Grant · Acquired 6,500 · Balance 6,500 F1: The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). |
Filing footnotes · ownership attribution and instrument terms
F1: The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2026 Filed Jun 12, 2026 14:38 UTC | Instil Bio, Inc. TIL · Entity 7177 | GrantStock Option (Right to Buy) · Derivative | 6,500 | $0.00 Strike: $7.93 | $0.00 |
DisclosureSEC source: 0001851336-26-000002 · wk-form4_1781289534.xml · derivative · entry 1 Matcham George · CIK 0001851336 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 6,500 shares Expires 2036-06-10 F1 · derivative.exercise_date: The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). Read SEC document |
| May 28, 2025 Filed May 29, 2025 19:10 UTC | Instil Bio, Inc. TIL · Entity 7177 | GrantStock Option (Right to Buy) · Derivative | 6,500 | $0.00 Strike: $26.75 | $0.00 |
DisclosureSEC source: 0001789769-25-000066 · wk-form4_1748560241.xml · derivative · entry 1 Matcham George · CIK 0001851336 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 6,500 shares Expires 2035-05-27 F1 · derivative.exercise_date: The option will vest in 12 substantially equal monthly installments commencing on June 28, 2025, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). Read SEC document |
| June 13, 2024 Filed Jun 13, 2024 17:03 UTC | Instil Bio, Inc. TIL · Entity 7177 | GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $10.50 | $0.00 |
DisclosureSEC source: 0001789769-24-000067 · wk-form4_1718312594.xml · derivative · entry 1 Matcham George · CIK 0001851336 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2034-06-12 F1 · derivative.exercise_date: The option will vest in 12 substantially equal monthly installments commencing on July 13, 2024, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). Read SEC document |
| June 14, 2023 Filed Jan 10, 2024 19:49 UTC | Instil Bio, Inc. TIL · Entity 7177 | GrantStock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0001789769-24-000007 · wk-form4_1704934135.xml · derivative · entry 1 Matcham George · CIK 0001851336 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2033-06-13 F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date. Read SEC document |
| May 20, 2022 Filed May 25, 2022 17:57 UTC | Instil Bio, Inc. TIL · Entity 7177 | GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001789769-22-000045 · wf-form4_165351582144757.xml · derivative · entry 1 Matcham George · CIK 0001851336 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-05-19 F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 20:54 UTC | Instil Bio, Inc. TIL · Entity 7177 | GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-21-022475 · doc4.xml · derivative · entry 1 Matcham George · CIK 0001851336 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2031-03-18 F1 · derivative.exercise_date: The option will vest in 36 equal monthly installments commencing on April 18, 2021, subject to the Report Person's continued service as a director through the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.